Orlistat PD Endpoint Determination during BE study [Design Issues]

posted by nobody – 2015-03-04 11:39 (4128 d 10:50 ago) – Posting: # 14549
Views: 6,904

...but appears doable, as I found at least one EPAR on such a study. As usual in recent times, no sample size was stated, but as CVintras were provided, apparently between 40 and 50 volunteers were included... Most likely based on one of these infamous (dubious?) pilot studies :-D

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
153 visitors (0 registered, 153 guests [including 31 identified bots]).
Forum time: 23:30 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5